BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17659475)

  • 1. Therapeutic potential of neuronal two-pore domain potassium-channel modulators.
    Mathie A; Veale EL
    Curr Opin Investig Drugs; 2007 Jul; 8(7):555-62. PubMed ID: 17659475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TREK K2P channels and their role in general anaesthesia and neuroprotection.
    Franks NP; Honoré E
    Trends Pharmacol Sci; 2004 Nov; 25(11):601-8. PubMed ID: 15491783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?
    Vivier D; Bennis K; Lesage F; Ducki S
    J Med Chem; 2016 Jun; 59(11):5149-57. PubMed ID: 26588045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GI-530159, a novel, selective, mechanosensitive two-pore-domain potassium (K
    Loucif AJC; Saintot PP; Liu J; Antonio BM; Zellmer SG; Yoger K; Veale EL; Wilbrey A; Omoto K; Cao L; Gutteridge A; Castle NA; Stevens EB; Mathie A
    Br J Pharmacol; 2018 Jun; 175(12):2272-2283. PubMed ID: 29150838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of TREK currents by the neuroprotective agent riluzole in mouse sympathetic neurons.
    Cadaveira-Mosquera A; Ribeiro SJ; Reboreda A; Pérez M; Lamas JA
    J Neurosci; 2011 Jan; 31(4):1375-85. PubMed ID: 21273422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TREK-1, a K+ channel involved in neuroprotection and general anesthesia.
    Heurteaux C; Guy N; Laigle C; Blondeau N; Duprat F; Mazzuca M; Lang-Lazdunski L; Widmann C; Zanzouri M; Romey G; Lazdunski M
    EMBO J; 2004 Jul; 23(13):2684-95. PubMed ID: 15175651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of temperature-sensitive leak K
    Viatchenko-Karpinski V; Ling J; Gu JG
    Mol Brain; 2018 Jul; 11(1):40. PubMed ID: 29980241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of the human detrusor to stretch is regulated by TREK-1, a two-pore-domain (K2P) mechano-gated potassium channel.
    Lei Q; Pan XQ; Chang S; Malkowicz SB; Guzzo TJ; Malykhina AP
    J Physiol; 2014 Jul; 592(14):3013-30. PubMed ID: 24801307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective Small Molecule Activators of TREK-2 Channels Stimulate Dorsal Root Ganglion c-Fiber Nociceptor Two-Pore-Domain Potassium Channel Currents and Limit Calcium Influx.
    Dadi PK; Vierra NC; Days E; Dickerson MT; Vinson PN; Weaver CD; Jacobson DA
    ACS Chem Neurosci; 2017 Mar; 8(3):558-568. PubMed ID: 27805811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sipatrigine could have therapeutic potential for major depression and bipolar depression through antagonism of the two-pore-domain K+ channel TREK-1.
    Tsai SJ
    Med Hypotheses; 2008; 70(3):548-50. PubMed ID: 17703894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiology and pharmacology of tandem domain potassium channel TREK-1 related BDNF synthesis in rat astrocytes.
    Lu L; Wang W; Peng Y; Li J; Wang L; Wang X
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Apr; 387(4):303-12. PubMed ID: 24402080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-Pore Domain Potassium Channels as Drug Targets: Anesthesia and Beyond.
    Mathie A; Veale EL; Cunningham KP; Holden RG; Wright PD
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():401-420. PubMed ID: 32679007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging roles for two-pore-domain potassium channels and their potential therapeutic impact.
    Bayliss DA; Barrett PQ
    Trends Pharmacol Sci; 2008 Nov; 29(11):566-75. PubMed ID: 18823665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotics inhibit TREK but not TRAAK channels.
    Thümmler S; Duprat F; Lazdunski M
    Biochem Biophys Res Commun; 2007 Mar; 354(1):284-9. PubMed ID: 17222806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Pharmacology of Two-Pore Domain Potassium Channels.
    Kamuene JM; Xu Y; Plant LD
    Handb Exp Pharmacol; 2021; 267():417-443. PubMed ID: 33880623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in expression of some two-pore domain potassium channel genes (KCNK) in selected brain regions of developing mice.
    Aller MI; Wisden W
    Neuroscience; 2008 Feb; 151(4):1154-72. PubMed ID: 18222039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of K2P channels in sensory and motor neurons of the autonomic nervous system.
    Cadaveira-Mosquera A; Pérez M; Reboreda A; Rivas-Ramírez P; Fernández-Fernández D; Lamas JA
    J Mol Neurosci; 2012 Sep; 48(1):86-96. PubMed ID: 22544515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixing and matching TREK/TRAAK subunits generate heterodimeric K2P channels with unique properties.
    Blin S; Ben Soussia I; Kim EJ; Brau F; Kang D; Lesage F; Bichet D
    Proc Natl Acad Sci U S A; 2016 Apr; 113(15):4200-5. PubMed ID: 27035965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein and Chemical Determinants of BL-1249 Action and Selectivity for K
    Pope L; Arrigoni C; Lou H; Bryant C; Gallardo-Godoy A; Renslo AR; Minor DL
    ACS Chem Neurosci; 2018 Dec; 9(12):3153-3165. PubMed ID: 30089357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PIP
    Rivas-Ramírez P; Reboreda A; Rueda-Ruzafa L; Herrera-Pérez S; Lamas JA
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.